Free Trial

Inozyme Pharma (INZY) Short Interest Ratio & Short Volume

$4.51
+0.11 (+2.50%)
(As of 04:00 PM ET)

Inozyme Pharma Short Interest Data

Current Short Interest
2,690,000 shares
Previous Short Interest
3,390,000 shares
Change Vs. Previous Month
-20.65%
Dollar Volume Sold Short
$12.56 million
Short Interest Ratio
4.1 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
61,860,000 shares
Float Size
41,620,000 shares
Short Percent of Float
6.46%
Today's Trading Volume
354,512 shares
Average Trading Volume
568,822 shares
Today's Volume Vs. Average
62%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Inozyme Pharma ?

Sign up to receive the latest short interest report for Inozyme Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

INZY Short Interest Over Time

INZY Days to Cover Over Time

INZY Percentage of Float Shorted Over Time

Inozyme Pharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20242,690,000 shares $12.56 million -20.7%6.5%4.1 $4.67
4/30/20243,390,000 shares $14.95 million +7.6%8.2%5 $4.41
4/15/20243,150,000 shares $14.84 million +22.1%7.7%4.7 $4.71
3/31/20242,580,000 shares $19.76 million +8.4%6.3%4.2 $7.66
3/15/20242,380,000 shares $14.02 million +2.6%5.8%4.6 $5.89
2/29/20242,320,000 shares $14.76 million -3.3%5.6%4.8 $6.36
2/15/20242,400,000 shares $13.70 million -16.4%5.8%5.4 $5.71
1/31/20242,870,000 shares $15.79 million +4.7%6.8%6.9 $5.50
1/15/20242,740,000 shares $11.54 million -10.8%6.5%6.7 $4.21
12/31/20233,070,000 shares $13.08 million +91.9%7.2%7.6 $4.26
12/15/20231,600,000 shares $6.43 million -28.6%3.8%3.7 $4.02
11/30/20232,240,000 shares $8.62 million -0.4%5.3%4.5 $3.85
11/15/20232,250,000 shares $7.20 million +8.2%5.3%4.2 $3.20
10/31/20232,080,000 shares $6.18 million -15.5%4.7%3.6 $2.97
10/15/20232,460,000 shares $8.35 million +6.5%5.5%3.7 $3.40
9/30/20232,310,000 shares $9.70 million +12.7%5.2%3.3 $4.20
9/15/20232,050,000 shares $8.82 million +21.3%4.6%3 $4.30
8/31/20231,690,000 shares $8.28 million -17.2%4.5%2.6 $4.90
8/15/20232,040,000 shares $9.83 million +11.5%5.4%3.3 $4.82
7/31/20231,830,000 shares $9.33 million +7.7%4.0%2.8 $5.10
7/15/20231,700,000 shares $10.35 million +37.1%4.9%3.1 $6.09
6/30/20231,240,000 shares $6.91 million +248.1%3.5%2 $5.57
6/15/2023356,200 shares $2.07 million +24.9%1.0%0.5 $5.81
5/31/2023285,100 shares $1.71 million -53.0%0.8%0.4 $5.99
5/15/2023606,300 shares $3.93 million No Change1.7%0.7 $6.49
10/31/2022166,500 shares $293,040.00 -4.8%N/A2.3 $1.76
10/15/2022174,800 shares $457,976.00 -4.4%N/A2.9 $2.62
9/30/2022182,900 shares $490,172.00 No ChangeN/A2.4 $2.68
9/15/2022182,900 shares $610,886.00 -7.6%0.8%1.5 $3.34
8/31/2022197,900 shares $593,700.00 -25.9%0.9%1.2 $3.00
8/15/2022267,000 shares $1.00 million -18.8%1.2%1.5 $3.76
7/31/2022328,800 shares $1.21 million -26.3%N/A1.7 $3.69
7/15/2022446,200 shares $2.23 million -47.1%N/A1.8 $5.00
6/30/2022842,900 shares $4.02 million -2.5%N/A2.8 $4.77
6/15/2022864,400 shares $4.02 million +0.3%N/A2.8 $4.65
5/31/2022861,600 shares $3.18 million +13.8%N/A3.5 $3.69
5/15/2022757,200 shares $3.20 million -13.6%N/A3.4 $4.23
4/30/2022876,200 shares $3.46 million +118.3%N/A4.2 $3.95
4/15/2022401,300 shares $1.71 million +23.5%1.7%2.3 $4.26
3/31/2022325,000 shares $1.33 million +12.2%N/A3.7 $4.09
Write this ticker symbol down… (Ad)

A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.

Discover the #1 company leading this revolution
3/15/2022289,700 shares $1.17 million -3.9%2.1%4.4 $4.03
2/28/2022301,300 shares $1.74 million +9.7%2.2%4.5 $5.77
2/15/2022274,700 shares $1.95 million +5.2%2.4%4.3 $7.10
1/31/2022261,200 shares $1.74 million +57.7%2.2%4.6 $6.68
1/15/2022165,600 shares $1.12 million +8.2%N/A3.1 $6.74
12/31/2021153,000 shares $1.04 million -13.6%1.3%2.9 $6.82
12/15/2021177,000 shares $987,660.00 -3.2%1.5%2.8 $5.58
11/30/2021182,800 shares $1.45 million +4.1%1.6%2.4 $7.94
11/15/2021175,600 shares $1.76 million -7.1%1.5%2.1 $10.00
10/29/2021189,100 shares $1.77 million -3.2%1.7%2.3 $9.34
10/15/2021195,400 shares $1.81 million -14.2%1.8%2.2 $9.25
9/30/2021227,800 shares $2.64 million +11.5%2.1%2.5 $11.59
9/15/2021204,300 shares $2.56 million -43.5%1.9%2.4 $12.55
8/31/2021361,500 shares $5.57 million -5.9%3.3%5.2 $15.42
8/13/2021384,100 shares $6.10 million +3.4%3.5%6.3 $15.88
7/30/2021371,400 shares $6.23 million +32.0%3.4%5.9 $16.77
7/15/2021281,300 shares $5.12 million -78.4%2.8%4.8 $18.19
6/30/20211,300,000 shares $22.15 million +26.2%12.7%24.2 $17.04
6/15/20211,030,000 shares $17.64 million +15.4%10.1%21.5 $17.13
5/28/2021892,200 shares $14.60 million +2.4%8.7%19.7 $16.36
5/14/2021871,000 shares $13.23 million -39.5%8.5%18.3 $15.19
4/30/20211,440,000 shares $26.40 million +0.7%14.1%27.8 $18.33
4/15/20211,430,000 shares $27.01 million +8.3%N/A22.9 $18.89
3/31/20211,320,000 shares $24.20 million +20.0%16.3%20.6 $18.33
3/15/20211,100,000 shares $23.38 million No Change14.9%16.4 $21.25
2/26/20211,100,000 shares $22.98 million +8.9%14.9%18.6 $20.89
2/12/20211,010,000 shares $20.16 million +85.0%13.7%17.7 $19.96
1/29/2021546,000 shares $12.49 million +1.8%7.4%9.8 $22.88
1/15/2021536,300 shares $14.19 million No Change7.7%13.5 $26.45

INZY Short Interest - Frequently Asked Questions

What is Inozyme Pharma's current short interest?

Short interest is the volume of Inozyme Pharma shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 2,690,000 shares of INZY short. 6.46% of Inozyme Pharma's shares are currently sold short. Learn More on Inozyme Pharma's current short interest.

What is a good short interest ratio for Inozyme Pharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INZY shares currently have a short interest ratio of 4.0. Learn More on Inozyme Pharma's short interest ratio.

What is a good short interest percentage for Inozyme Pharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.46% of Inozyme Pharma's floating shares are currently sold short.

Is Inozyme Pharma's short interest increasing or decreasing?

Inozyme Pharma saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 2,690,000 shares, a decrease of 20.6% from the previous total of 3,390,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Inozyme Pharma's float size?

Inozyme Pharma currently has issued a total of 61,860,000 shares. Some of Inozyme Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Inozyme Pharma currently has a public float of 41,620,000 shares.

How does Inozyme Pharma's short interest compare to its competitors?

6.46% of Inozyme Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Inozyme Pharma: Foghorn Therapeutics Inc. (5.35%), Eagle Pharmaceuticals, Inc. (9.97%), Prothena Co. plc (12.11%), Cassava Sciences, Inc. (26.68%), Arcturus Therapeutics Holdings Inc. (16.81%), Arcutis Biotherapeutics, Inc. (19.15%), Verona Pharma plc (7.01%), Bicycle Therapeutics plc (6.76%), Innoviva, Inc. (18.86%), OPKO Health, Inc. (26.01%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Inozyme Pharma stock?

Short selling INZY is an investing strategy that aims to generate trading profit from Inozyme Pharma as its price is falling. INZY shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Inozyme Pharma?

A short squeeze for Inozyme Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INZY, which in turn drives the price of the stock up even further.

How often is Inozyme Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INZY, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:INZY) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners